IMS Health has filed a public
registration statement with
the US Securities and Exchange
Commission related to a proposed
initial public offering of its shares.
To float under the name of
IMS Health Holdings Inc, copies
of a preliminary prospectus can
be obtained from JP Morgan or
Goldman Sachs, with the number
of shares and the price range not
having yet been determined.
However the documents reveal
that the move could raise as much
as US$100 million.
IMS Health said it expects to use
the net proceeds from the offering
to repay a portion of its existing
long-term debt, as well as for
“general corporate purposes”.
IMS is currently owned by private
equity firm TPG along with other
investors who privatised it in 2010
for US$5.2 billion.
The company’s total revenue
for the year to 30 Sep was $1.87
billion, up 4%.The above article was sent to subscribers in Pharmacy Daily's issue from 06 Jan 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 06 Jan 14
THE Pharmaceutical Society of Australia (PSA) awarded Brooke Shelly the prestigious 2024 PSA MIMS Credentialed Pharmacist of the Year award last Fri at the Credentialed Pharmacist Conference (CPC24) (PD breaking news).
THE Pharmaceutical Society of Australia (PSA) has unveiled a comprehensive membership package designed to provide robust support for credentialed pharmacists throughout their professional journey.
MEDICAL research produces better outcomes when people with lived experience are involved in the process, according to Breast Cancer Network Australia (BCNA).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.